Table 2.
All conflicts of interest disclosed n (%) | Some conflicts of interest undisclosed n (%) | All conflicts of interest undisclosed n (%) | No conflicts of interest identified* n (%) | Total (%) | |
---|---|---|---|---|---|
COI related to trial sponsor or manufacturer | 44 (14%) | 28 (9%) | 12 (4%) | 234 (74%) | 318 (100%) |
COI related to competing manufacturer | 10 (3%) | 30 (9%) | 49 (15%) | 229 (72%) | 318 (100%) |
COI related to any drug manufacturer | 15 (5%) | 71 (22%) | 66 (21%) | 166 (52%) | 318 (100%) |
*No conflicts of interest identified either in publication or in Danish Health Authority’s list.